Press Release

Crown Laboratories Announces New Chief Commercial Officer, John Peterson

Crown Laboratories Enhances Its Leadership Team to Support Dynamic Growing Portfolio

April 8, 2019

JOHNSON CITY, TN (Apr. 8, 2019)—Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skin care company, announced today that John Petersen has joined the organization as Chief Commercial Officer, a new position that will oversee all global commercial operations for Crown’s Therapeutic, Beauty and Prescription Portfolios.

Mr. Petersen most recently was Head of Consumer Dermatology for Sandoz. Previously, his career included AstraZeneca, Galderma, L’Oréal USA and Alcon. Mr. Petersen has significant sales and marketing experience including oversight of trade sales, demand planning, supply chain, sales and marketing for consumer, OTC and prescription brands. He has managed best selling brands, such as Cetaphil.

“We are excited to have John join Crown to lead our very talented global commercial team,” said Jeff Bedard, President and CEO of Crown. “Throughout his career, John has focused on building partnerships and developing strategies that enhance the brands under his management.  We have built a diverse global portfolio that requires broad commercial expertise and John has significant experience in driving results and achieving corporate objectives.”

“I am thrilled to be joining the Crown team,” added John Petersen. “The vision that has been established, as well as the recent acquisitions, clearly put us on an exciting growth trajectory. I am looking forward to leading and helping the team exceed the goals set before us.”

Back to News

About Crown Laboratories, Inc.

Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown’s unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become a leader in Dermatology and Aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for ten years and has expanded its distribution to over 50 countries. For more information, visit www.crownlaboratories.com.